In a recent paper, Horder and colleagues (Horder et al., 2010, J Psychopharmacol 25: 1277–1288) have suggested that the mainproblem in the Kirsch analysis is methodological. We argue that the results are similar irrespective of the method used. In our opinion the data suggest that placebo and drug effects are non-additive: antidepressants act independently of depression severity, while the placebo effect is present only in milder cases. While the response in the placebo group is due to unstable ‘noise’ and ‘artefacts’, the medication effect is reliable, valid and stable.
BarbuiCFurukawaTACiprianiA (2008) Effectiveness of paroxetine in the treatment of acute major depression in adults: a systematic re-examination of published and unpublished data from randomized trials. CMAJ178: 296–305.
2.
BechP (2001) Meta-analysis of placebo-controlled trials with mirtazapine using the core items of the Hamilton Depression Scale as evidence of a pure antidepressive effect in the short-term treatment of major depression. Int J Neuropsychopharmacol4: 337–345.
3.
BechP (2004) Modern psychometrics in clinimetrics: impact on clinical trials of antidepressants. Psychother Psychosom73: 134–138.
4.
BechP (2006) Rating scales in depression: limitations and pitfalls. Dialogues Clin Neurosci8: 207–215.
5.
BechP (2010) Is the antidepressive effect of second-generation antidepressants a myth?Psychol Med40: 181–186.
6.
BechPCialdellaPHaughMC. (2000) Meta-analysis of randomised controlled trials of fluoxetine v. placebo and tricyclic antidepressants in the short-term treatment of major depression. Br J Psychiatry176: 421–428.
7.
BechPTanghojPCialdellaP. (2004) Escitalopram dose–response revisited: an alternative psychometric approach to evaluate clinical effects of escitalopram compared to citalopram and placebo in patients with major depression. Int J Neuropsychopharmacol7: 283–290.
8.
BlandJAltmanD (1994a) Regression towards the mean. BMJ308: 1499.
9.
BlandJAltmanD (1994b) Some examples of regression towards the mean. BMJ309: 780.
10.
BroichK (2009) Committee for Medicinal Products for Human Use (CHMP) assessment on efficacy of antidepressants. Eur Neuropsychopharmacol19: 305–308.
11.
CiprianiAFurukawaTASalantiG. (2009) Comparative efficacy and acceptability of 12 new-generation antidepressants: amultiple-treatments meta-analysis. Lancet373: 746–758.
12.
CuijpersPSmitFBohlmeijerE. (2010a) Efficacy of cognitive-behavioural therapy and other psychological treatments for adultdepression: meta-analytic study of publication bias. Br J Psychiatry196: 173–178.
13.
CuijpersPvan StratenASchuurmansJ. (2010b) Psychotherapy for chronic major depression and dysthymia: a meta-analysis. Clin Psychol Rev30: 51–62.
14.
FountoulakisKNKaprinisSGSt KaprinisG (2004) Geriatric depression: a challenge for the 21st century. Aging Clin Exp Res16: 173–175.
15.
FountoulakisKNMöllerHJ (2010) Efficacy of antidepressants: a re-analysis and re-interpretation of the Kirsch data. Int J Neuropsychopharmacol1–8.
16.
FountoulakisKNO’HaraRIacovidesA. (2003) Unipolar late-onset depression: A comprehensive review. Ann Gen Hosp Psychiatry2: 11.
17.
FournierJCDeRubeisRJHollonSD. (2010) Antidepressant drug effects and depression severity: a patient-level meta-analysis. JAMA303: 47–53.
18.
GelfandSUllmannLPKrasnerL (1963) The placebo response: an experimental approach. J Nerv Ment Dis136: 379–387.
19.
GhaemiSN (2008) Why antidepressants are not antidepressants: STEP-BD, STAR*D, and the return of neurotic depression. Bipolar Disord10: 957–968.
20.
HorderJMatthewsPWaldmannR (2010) Placebo, Prozac and PLoS: significant lessons for psychopharmacology. J Psychopharmacol25: 1277–1288.
21.
KaptchukTJKelleyJMConboyLA. (2008) Components of placebo effect: randomised controlled trial in patients with irritable bowel syndrome. BMJ336: 999–1003.
22.
KirschI (2000) Are drug and placebo effects in depression additive?Biol Psychiatry47: 733–735.
23.
KirschI (2004) Conditioning, expectancy, and the placebo effect: comment on Stewart-Williams and Podd (2004). Psychol Bull130: 341–343; discussion 344-345.
24.
KirschI (2005) Placebo psychotherapy: synonym or oxymoron?J Clin Psychol61: 791–803.
25.
KirschI (2008a) Antidepressant drugs ‘work’, but they are not clinically effective. Br J Hosp Med (Lond)69: 359.
26.
KirschI (2008b) Challenging received wisdom: antidepressants and the placebo effect. Mcgill J Med11: 219–222.
27.
KirschI (2009a) Antidepressants and the placebo response. Epidemiol Psichiatr Soc18: 318–322.
28.
KirschI (2009b) The Emperor’s New Drugs: Exploding the Antidepressant Myth. London: The Bodley Head.
29.
KirschIDeaconBJHuedo-MedinaTB. (2008) Initial severity and antidepressant benefits: a meta-analysis of data submitted to the Food and Drug Administration. PLoS Med5: e45.
30.
KirschIJohnsonBT (2008) Moving beyond depression: How full is the glass?BMJ336: 629–630.
31.
KirschIMoncrieffJ (2007) Clinical trials and the response rate illusion. Contemp Clin Trials28: 348–351.
32.
KonarskiJZKennedySHSegalZV. (2009) Predictors of nonresponse to cognitive behavioural therapy or venlafaxine using glucose metabolism in major depressive disorder. J Psychiatry Neurosci34: 175–180.
33.
MartinSDMartinERaiSS. (2001) Brain blood flow changes in depressed patients treated with interpersonal psychotherapy or venlafaxine hydrochloride: preliminary findings. Arch Gen Psychiatry58: 641–648.
34.
MaybergHSSilvaJABrannanSK. (2002) The functional neuroanatomy of the placebo effect. Am J Psychiatry159: 728–737.
35.
McAllister-WilliamsRH (2008) Do antidepressants work? A commentary on “Initial severity and antidepressant benefits: a meta-analysis of data submitted to the Food and Drug Administration” by Kirsch et al. Evid Based Ment Health11: 66–68.
36.
MöllerH (2009a) Antidepressants: controversies about their efficacy in depression, their effect on suicidality and their place in a complex psychiatric treatment approach. World J Biol Psychiatry10: 180–195.
37.
MöllerHMaierW (2010a) Evidence-based medicine in psychopharmacotherapy: possibilities, problems and limitations. Eur Arch Psychiatry Clin Neurosci260: 25–39.
38.
MöllerHJ (2008) Isn’t the efficacy of antidepressants clinically relevant? A critical comment on the results of the metaanalysis by Kirsch et al. 2008. Eur Arch Psychiatry Clin Neurosci258: 451–455.
39.
MöllerHJ (2009b) Antidepressants: controversies about their efficacy in depression, their effect on suicidality and their place in a complex psychiatric treatment approach. World J Biol Psychiatry10: 180–195.
40.
MöllerHJ (2009c) Is evidence sufficient for evidence-based medicine?Eur Arch Psychiatry Clin Neurosci259(Suppl. 2): S167–S172.
41.
MöllerHJBroichK (2010) Principle standards and problems regarding proof of efficacy in clinical psychopharmacology. Eur Arch Psychiatry Clin Neurosci260: 3–16.
42.
MöllerHJMaierW (2010b) Evidence-based medicine in psychopharmacotherapy: possibilities, problems and limitations. Eur Arch Psychiatry Clin Neurosci260: 25–39.
43.
MoncrieffJKirschI (2005) Efficacy of antidepressants in adults. BMJ331: 155–157.
44.
MoncrieffJWesselySHardyR (2004) Active placebos versus antidepressants for depression. Cochrane Database Syst RevCD003012.
45.
PosternakMAZimmermanMKeitnerGI. (2002) A reevaluation of the exclusion criteria used in antidepressant efficacy trials. Am J Psychiatry159: 191–200.
46.
RushAJ (2007) STAR*D: what have we learned?Am J Psychiatry164: 201–204.
47.
TrivediMHRushH (1994) Does a placebo run-in or a placebo treatment cell affect the efficacy of antidepressant medications?Neuropsychopharmacology11: 33–43.
48.
TurnerEHMatthewsAMLinardatosE. (2008) Selective publication of antidepressant trials and its influence on apparent efficacy. N Engl J Med358: 252–260.
49.
WaringDR (2008) The antidepressant debate and the balanced placebo trial design: an ethical analysis. Int J Law Psychiatry31: 453–462.
50.
WhalleyBHylandMEKirschI (2008) Consistency of the placebo effect. J Psychosom Res64: 537–541.
